Kurse werden geladen...
Prognose
Kaufen | 1 |
Halten | 0 |
Verkaufen | 0 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Zedcor Inc. Reports Record Quarterly Results, Including $11.5 million in Revenue and $4.1 million in Adjusted EBITDA for the First Quarter 2025
Calgary, Alberta--(Newsfile Corp. - May 21, 2025) - Zedcor Inc. (TSXV: ZDC) ("Zedcor" or the "Company") is pleased to announce its financial and operating results for the three months ended March 31, 2025. Highlights include: Record quarterly revenue of $11.5 million, representing an increase of 87% year-over-year and 11% quarter-over-quarter Record quarterly Adjusted EBITDA of $4.1 million, representing an increase of 116% year-over-year Adjusted EBITDA margin was 36%, despite significant expansion costs out of the U.S., driven by strong contribution margins in Canada and increased operational efficiency from its AI at-the-edge cameras Deployed 229 MobileyeZTM security towers during the three months ended March 31, 2025; these security towers were deployed throughout North America, with a focus on US expansion, and realized total fleet utilization rates above 90% for the quarter U.S. revenue was 29% of total revenue for Q1 2025 Manufacturing monthly run rate eclipsed 100 units with anticipated growth to 120 units in Q2 2025 The Company expects to be largely insulated from tariffs as manufacturing is based in Houston, Texas and camera costs have been locked in for 2025, while there have been no signs of demand waning, despite the geopolitical risks in the market Zedcor generated revenue of $11.5 million for the three months ended March 31, 2025, and Adjusted EBITDA of $4.1 million.» Mehr auf newsfilecorp.com
Zedcor Inc. Announces Timing of First Quarter Financial Results Conference Call
Calgary, Alberta--(Newsfile Corp. - May 15, 2025) - Zedcor Inc. (TSXV: ZDC) ("Zedcor" or the "Company") is pleased to announce that the Company will release its first quarter financial results for the period ended March 31, 2025, after markets close on Wednesday, May 21, 2025. The Company will also host a conference call to discuss the results on Thursday, May 22 at 10:00 am ET (8:00 am MT).» Mehr auf newsfilecorp.com
Zedcor Inc. Reports Quarterly Results, Including $10.3 million in Revenue and $4.0 million in Adjusted EBITDA for the Fourth Quarter 2024
Calgary, Alberta--(Newsfile Corp. - April 10, 2025) - Zedcor Inc. (TSXV: ZDC) ("Zedcor" or the "Company") is pleased to announce its financial and operating results for the three and twelve months ended December 31, 2024. Highlights include: Record quarterly revenue of $10.3 million, representing an increase of 78% year-over-year and 12% quarter-over-quarter Record quarterly Adjusted EBITDA of $4.0 million, representing an increase of 185% year-over-year and 18% quarter-over-quarter Adjusted EBITDA margin increased to 39%, despite significant scaling costs out of the U.S., driven by strong contribution margins in Canada and increased operational efficiency from its AI at-the-edge cameras Deployed 186 MobileyeZTM security towers during the three months ended December 31, 2024 and 512 MobileyeZTM security towers during the year ended December 31, 2024; these security towers were deployed throughout North America and realized total fleet utilization rates above 90% for the quarter U.S. revenue exceeded 20% of total revenues for Q4 2024 The Company expects to be largely insulated from tariffs as manufacturing is based in Houston, Texas and camera costs have been locked in for 2025, while there have been no signs of demand waning, despite the geopolitical risks in the market Zedcor generated revenue of $10.3 million and $33.0 million for the three and twelve months ended December 31, 2024, respectively, and Adjusted EBITDA of $4.0 million and $12.0 million.» Mehr auf newsfilecorp.com
Historische Dividenden
Alle Dividenden KennzahlenUnternehmenszahlen
(EUR) | Sep. 2024 | |
---|---|---|
Umsatz | 6,08 Mio | - |
Bruttoeinkommen | 3,59 Mio | - |
Nettoeinkommen | 205,78k | - |
EBITDA | 1,65 Mio | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 197,24 Mio€ |
Anzahl Aktien | 96,05 Mio |
52 Wochen-Hoch/Tief | 2,28€ - 0,34€ |
Dividenden | Nein |
Beta | 2,47 |
KGV (PE Ratio) | 212,29 |
KGWV (PEG Ratio) | 0,31 |
KBV (PB Ratio) | 10,81 |
KUV (PS Ratio) | 11,33 |
Unternehmensprofil
Neurocrine Biosciences, Inc. erforscht, entwickelt und vermarktet Arzneimittel für neurologische, endokrine und psychiatrische Erkrankungen. Das Portfolio des Unternehmens umfasst Behandlungen für Spätdyskinesien, die Parkinson-Krankheit, Endometriose und Uterusmyome sowie klinische Programme in verschiedenen Therapiebereichen. Das führende Produkt ist INGREZZA, ein VMAT2-Inhibitor zur Behandlung von Spätdyskinesien. Zu den kommerziellen Produkten des Unternehmens gehören ONGENTYS, ein Katechol-O-Methyltransferase-Hemmer, der als Zusatztherapie zu Levodopa/DOPA-Decarboxylase-Hemmern bei Parkinson-Patienten eingesetzt wird, ORILISSA für die Behandlung von mäßigen bis starken Endometrioseschmerzen bei Frauen und ORIAHNN, eine nicht-chirurgische orale Medikamentenoption für die Behandlung von starken Menstruationsblutungen im Zusammenhang mit Uterusmyomen bei Frauen vor der Menopause. Zu den Produktkandidaten des Unternehmens in der klinischen Entwicklung gehören NBI-921352 zur Behandlung pädiatrischer Patienten sowie erwachsener fokaler Epilepsie-Indikationen und NBI-827104 zur Behandlung seltener pädiatrischer Epilepsie und essentiellen Tremors. Zu den Produkten des Unternehmens in der klinischen Entwicklung gehören auch NBI-1065845 zur Behandlung von schweren depressiven Störungen, NBI-1065846 zur Behandlung von Anhedonie bei schweren depressiven Störungen und NBI-118568 zur Behandlung von Schizophrenie. Es hat Lizenz- und Kooperationsvereinbarungen mit Heptares Therapeutics Limited, Takeda Pharmaceutical Company Limited, Idorsia Pharmaceuticals Ltd, Xenon Pharmaceuticals Inc, Voyager Therapeutics, Inc, BIAL Portela & Ca, S.A., Mitsubishi Tanabe Pharma Corporation und AbbVie Inc. Neurocrine Biosciences, Inc. wurde 1992 gegründet und hat seinen Hauptsitz in San Diego, Kalifornien.
Name | Zedcor |
CEO | Todd Michael Ziniuk |
Sitz | Calgary, ab USA |
Website | |
Industrie | Öl, Gas und nicht erneuerbare Brennstoffe |
Börsengang | |
Mitarbeiter | 100 |
Ticker Symbole
Börse | Symbol |
---|---|
Tsxv | ZDC.V |
Pnk | CRFQF |
Assets entdecken
Shareholder von Zedcor investieren auch in folgende Assets